ACB News and Press, Aurora Cannabis Inc. From 02/16/24

2024-02-16 14:15:02 ET Canaccord Genuity analyst issues POSITIVE recommendation for ACB on February 16, 2024 02:02PM ET. The previous analyst recommendation was Hold. ACB was trading at $0.39 at issue of the analyst recommendation. The overall analyst consensus : HOLD. ...

Marijuana businesses in Thailand are preparing for major regulatory and legal changes as the country works to keep recreational sales in check and make the industry primarily medicinal again. The latest draft marijuana law from the Thai government is focused on eliminating the vacuum that allow...

2024-02-12 13:37:10 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Recent developments underscore the turbulent scenario investors are grappling with in the cannabis sphere, shedding light on the cannabis stocks to sell. While the U.S Drug Enforcement Ad...

2024-02-11 09:50:00 ET The S&P 500 is in a bull market, but some companies aren't keeping pace. On the one hand, stocks that get left behind during a bull run can be worth investing in, provided they have significant upside potential and their slump is temporary. But other times, co...

2024-02-10 18:25:10 ET Top Performer’s Surge in the Cannabis Sector In February 2024, top Canadian cannabis stocks showed mixed performance amid evolving market dynamics. Companies like Canopy Growth, Aurora Cannabis, and Tilray Brands remained focal points for investors. Mar...

2024-02-10 03:40:00 ET Summary The Bengal Catalyst Fund continues to perform well in early 2024 as well - as of this writing, the Fund is now solidly in the green since inception vs. MSOS -75%. Instead of SAFE Banking, the latest “catalyst” is the perceived likely re...

2024-02-09 16:35:05 ET More on Aurora Cannabis Aurora Cannabis Inc. (ACB) Q3 2024 Earnings Call Transcript Aurora Cannabis buys MedReleaf Australia at A$50M enterprise value Aurora Cannabis reports Q3 results; initiates Q4 2024 outlook Seeking Alpha’s ...

2024-02-08 13:30:15 ET Image source: The Motley Fool. Aurora Cannabis (NASDAQ: ACB) Q3 2024 Earnings Call Feb 08, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Aurora Cannabis (ACB) Q3 2024 Earnings Call Transcript

2024-02-08 10:22:02 ET Aurora Cannabis Inc. (ACB) Q3 2024 Earnings Conference Call February 08, 2024 08:00 AM ET Company Participants Ananth Krishnan - VP, Corporate Development & Strategy Miguel Martin - CEO Glen Ibbott - CFO Conference Call Participan...

2024-02-08 08:21:58 ET Aurora Cannabis Inc (NASDAQ: ACB) is in focus today after buying the remaining 90% stake in MedReleaf Australia for about AU$50 million ($32.45 million). Details of Aurora-MedReleaf transaction The licensed cannabis producer paid $9.45 million in cash and ...